Author Correction: Functionally selective signaling and broad metabolic benefits by novel insulin receptor partial agonists
Year: 2024
Type: erratum
Abstract: This Article contains an error in the spelling of the author Yacob Gomez-Llorente, which is incorrectly given without hyphenation as Yacob Gomez Llorente. The error has been corrected in the PDF and HTML versions of the Article.
Source: Nature Communications
Authors: Margaret Wu, Ester Carballo-Jane, Haihong Zhou, Peter Zafian, Ge Dai, Mindy Liu, Julie Lao, Terri Kelly, Dan Shao, Judith Gorski, Dmitri Pissarnitski, Ahmet Kekec, Ying Chen, Stephen F. Previs, Giovanna Scapin, Yacob Gomez-Llorente, Scott A. Hollingsworth, Lin Yan, Danqing Feng, Pei Huo, Geoffrey Walford, Mark D. Erion, David E. Kelley, Songnian Lin, James Mu
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $6,790
OpenAlex ID: W4391132482